Last update 01 Nov 2024
Medinno, Inc.

Medinno, Inc.

Private Company|
2018|
Seoul, South Korea
|
10-50
|
www.medinno.kr

Overview

Tags

Nervous System Diseases
Cardiovascular Diseases
Other Diseases
Neural stem cell therapy
Mesenchymal stem cell therapy
Gene therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases7
Immune System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Neural stem cell therapy3
Mesenchymal stem cell therapy2
Stem cell therapy1
Gene therapy1

Related

7
Drugs associated with Medinno, Inc.
MS-2001
Target-
Mechanism-
Active Org.
Medinno, Inc.Medinno, Inc.
Originator Org.
Medinno, Inc.Medinno, Inc.
Active Indication
Cerebral Intraventricular Hemorrhage
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
MS-1901
Target-
Mechanism-
Active Org.
Medinno, Inc.Medinno, Inc.
Originator Org.
Medinno, Inc.Medinno, Inc.
Active Indication
Hypoxia-Ischemia, Brain
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
Brain Tumor(Medinno)
Target-
Mechanism-
Active Org.
Medinno, Inc.Medinno, Inc.
Originator Org.
Medinno, Inc.Medinno, Inc.
Active Indication
Brain Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Medinno, Inc.
KCT0004851 / RecruitingPhase 1
An Open-label, dose-escalation, phase 1 clinical trial to determine the safety and dose of HIEstem, a treatment for neonatal intractable brain diseases
100 Clinical Results associated with Medinno, Inc.
Login to view more data
0 Patents (Medical) associated with Medinno, Inc.
Login to view more data
100 Deals associated with Medinno, Inc.
Login to view more data
100 Translational Medicine associated with Medinno, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 28 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
5
2
Phase 1 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
MS-1901
Hypoxia-Ischemia, Brain
More
Phase 1
MS-2001
Cerebral Intraventricular Hemorrhage
More
Phase 1
Multiple Sclerosis(Medinno)
Multiple Sclerosis
More
Preclinical
MS-2201
Stroke
More
Preclinical
Brain Tumor(Medinno)
Brain Cancer
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free